Nonapeptide-1 (INCI name), also known as Melanostatine, is a synthetic biomimetic nonapeptide that functions as a highly selective antagonist of α-melanocyte-stimulating hormone (α-MSH) . By competitively binding to the melanocortin-1 receptor (MC1R) on melanocytes, Nonapeptide-1 effectively interrupts the primary signaling pathway responsible for melanin synthesis .
This targeted mechanism makes Nonapeptide-1 a distinct alternative to traditional skin brightening agents. Unlike hydroquinone or certain acids that may cause irritation or cytotoxicity, Nonapeptide-1 achieves a reduction in melanin synthesis of approximately 33% without complete suppression of melanogenesis, preserving the skin's natural defense against ultraviolet radiation . Clinical observations have demonstrated significant reversal of sunspots and hyperpigmentation within 28 days of consistent application .
